Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers

Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers

<h3>Background</h3> Genetic factors have a substantial role in determining development of rheumatoid arthritis (RA), and are likely to account for 50–60% of disease susceptibility. Genome-wide association studies have identified non-human leucocyte antigen RA susceptibility loci which as...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Darren Plant, Edward Flynn, Hamdi Mbarek, Philippe Dieudé, François Cornélis, Lisbeth Ärlestig, Solbritt Rantapää‐Dahlqvist, GN Goulielmos, Dimitrios T. Boumpas, Prodromos Sidiropoulos, Julia S. Johansen, Lykke Midtbøll Ørnbjerg, Merete Lund Hetland, Lars Klareskog, Andrew Filer, Christopher D. Buckley, Karim Raza, T Witte, Reinhold E. Schmidt, Jane Worthington
Hōputu:	Revisão
Reo:	Ingarihi
I whakaputaina:	2010
Urunga tuihono:	https://doi.org/10.1136/ard.2009.121020 https://ard.bmj.com/content/annrheumdis/69/8/1548.full.pdf
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers
mā: Plant, Darren, me ētahi atu.
I whakaputaina: (2010)

Identification of the Tyrosine-Protein Phosphatase Non-Receptor Type 2 as a Rheumatoid Arthritis Susceptibility Locus in Europeans
mā: Cobb, Joanna E., me ētahi atu.
I whakaputaina: (2013)

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease
mā: Johansson, Martin, me ētahi atu.
I whakaputaina: (2006)

Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis
mā: Surowiec, Izabella, me ētahi atu.
I whakaputaina: (2016)

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.
mā: Martin Johansson, me ētahi atu.
I whakaputaina: (2005)

Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis
mā: Izabella Surowiec, me ētahi atu.
I whakaputaina: (2016)

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
mā: Boman, Antonia, me ētahi atu.
I whakaputaina: (2017)

Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
mā: Renman, Emma, me ētahi atu.
I whakaputaina: (2020)

Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden
mā: Jönsson, Elias, me ētahi atu.
I whakaputaina: (2021)

Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
mā: Ärlestig, Lisbeth, me ētahi atu.
I whakaputaina: (2011)

Vitamin D in individuals before onset of rheumatoid arthritis - relation to vitamin D binding protein and its associated genetic variants
mā: Brink, Mikael, me ētahi atu.
I whakaputaina: (2018)

Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
mā: Lisbeth Ärlestig, me ētahi atu.
I whakaputaina: (2011)

Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis
mā: Johansson, Linda, me ētahi atu.
I whakaputaina: (2016)

Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis
mā: Linda Johansson, me ētahi atu.
I whakaputaina: (2016)

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study
mā: Kastbom, Alf, me ētahi atu.
I whakaputaina: (2012)

Abdominal obesity, gender and the risk of rheumatoid arthritis – a nested case–control study
mā: Ljung, Lotta, me ētahi atu.
I whakaputaina: (2016)

Individuals at risk of seropositive rheumatoid arthritis- the evolving story
mā: Dahlqvist, Solbritt Rantapää, me ētahi atu.
I whakaputaina: (2019)

Abdominal obesity, gender and the risk of rheumatoid arthritis – a nested case–control study
mā: Lotta Ljung, me ētahi atu.
I whakaputaina: (2016)

Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
mā: Prodromos Sidiropoulos, me ētahi atu.
I whakaputaina: (2008)

Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population
mā: Zervou, Maria I., me ētahi atu.
I whakaputaina: (2013)

Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete
mā: Elias Eliopoulos, me ētahi atu.
I whakaputaina: (2011)

Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis
mā: Grimsholm, Ola, me ētahi atu.
I whakaputaina: (2005)

Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis
mā: Grimsholm, Ola, me ētahi atu.
I whakaputaina: (2008)

Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case–control study
mā: Kokkonen, Heidi, me ētahi atu.
I whakaputaina: (2017)

Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: results from a nested case-control study
mā: B. Sundström, me ētahi atu.
I whakaputaina: (2014)

Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis.
mā: Ola Grimsholm, me ētahi atu.
I whakaputaina: (2005)

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.
mā: Solbritt Rantapää‐Dahlqvist, me ētahi atu.
I whakaputaina: (1991)

Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
mā: Sidiropoulos, Prodromos I, me ētahi atu.
I whakaputaina: (2008)

Rheumatoid Arthritis-associated Interstitial Lung Disease in Greece: A Multicentre Epidemiological and Clinical Study
mā: Karageorgas, Theofanis, me ētahi atu.
I whakaputaina: (2018)

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
mā: Marie Holmqvist, me ētahi atu.
I whakaputaina: (2010)

Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment
mā: Forsgren, Sture, me ētahi atu.
I whakaputaina: (2011)

Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study
mā: Bokarewa, Maria, me ētahi atu.
I whakaputaina: (2014)

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study
mā: Ljung, Lotta, me ētahi atu.
I whakaputaina: (2014)

Oral Microbiota Identifies Patients in Early Onset Rheumatoid Arthritis
mā: Esberg, Anders, me ētahi atu.
I whakaputaina: (2021)

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study
mā: Lotta Ljung, me ētahi atu.
I whakaputaina: (2014)

Oral Microbiota Identifies Patients in Early Onset Rheumatoid Arthritis
mā: Anders Esberg, me ētahi atu.
I whakaputaina: (2021)

Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis
mā: Solbritt Rantapää‐Dahlqvist, me ētahi atu.
I whakaputaina: (2006)

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis
mā: Berglin, Ewa, me ētahi atu.
I whakaputaina: (2004)

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis
mā: Ewa Berglin, me ētahi atu.
I whakaputaina: (2004)

Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis
mā: Juneblad, Kristina, me ētahi atu.
I whakaputaina: (2011)